Recently the combined effect of ACPA and RF on systemic inflammation was investigated in RA, showing that the combined presence of ACPA and RF was associated with higher levels of pro-inflammatory cytokines and increased acute phase reactants and disease activity [43]. The gene discussed is PRTN3; the disease is rheumatoid arthritis.